By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that its common stock has been added to the US large-cap Russell 1000 Index and the broad market Russell 3000 Index.

Russell Investments reconstituted its equity indexes after the close of the market on Friday, resulting in Qiagen's inclusion, the molecular diagnostics and sample prep technologies firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.